medical oncology

Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)
Floriane Jochum, Tamara De Rozario, Lise Lecointre, Emilie Faller, Thomas Boisrame, Yohann Dabi, Vincent Lavoué, Charles Coutant, Cyril Touboul, Pierre-Adrien Bolze, Alexandre Bricou, Geoffroy Canlorbe, Pierre Collinet, Cyrille Huchon, Sofiane Bendifallah, Lobna Ouldamer, Mathieu Mezzadri, Denis Querleu, Chérif Akladios

International Journal of Gynecologic Cancer Nov 2021, 31 (11) 1443-1452; DOI: 10.1136/ijgc-2021-002934
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey
Raffaella Cioffi, Giulia Sabetta, Emanuela Rabaiotti, Alice Bergamini, Luca Bocciolone, Giorgio Candotti, Massimo Candiani, Giorgio Valabrega, Giorgia Mangili, Sandro Pignata

International Journal of Gynecologic Cancer Oct 2021, 31 (10) 1363-1368; DOI: 10.1136/ijgc-2021-002784
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study
Giorgia Mangili, Giorgio Giorda, Gabriella Ferrandina, Gennaro Cormio, Chiara Cassani, Antonella Savarese, Saverio Danese, Marco Carnelli, Francesca Maria Vasta, Anna Myriam Perrone, Giovanna Scarfone, Sandro Pignata, Francesco Legge, Francesco Raspagliesi, Gianluca Taccagni, Massimo Candiani, Giorgio Bogani, Floriana Mascilini, Alice Bergamini

International Journal of Gynecologic Cancer Sep 2021, 31 (9) 1242-1247; DOI: 10.1136/ijgc-2021-002575
Association of patient-reported outcomes and ovarian cancer recurrence
Anette Stolberg Kargo, Pernille Tine Jensen, Kristina Lindemann, Niels Henrik Hjøllund, Gabor Istvan Liposits, Nicoline Raaschou-Jensen, Bettina Mølri Knudsen, Sören Möller, Dorte Gilså Hansen, Karina Dahl Steffensen

International Journal of Gynecologic Cancer Sep 2021, 31 (9) 1248-1259; DOI: 10.1136/ijgc-2021-002550
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study
Gennaro Daniele, Francesco Raspagliesi, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Simona Frezzini, Germana Tognon, Grazia Artioli, Angiolo Gadducci, Rossella Lauria, Annamaria Ferrero, Saverio Cinieri, Andrea De Censi, Enrico Breda, Paolo Scollo, Ugo De Giorgi, Andrea Alberto Lissoni, Dionyssios Katsaros, Domenica Lorusso, Vanda Salutari, Sabrina Chiara Cecere, Eleonora Zaccarelli, Margherita Nardin, Giorgio Bogani, Mariagrazia Distefano, Stefano Greggi, Maria Carmela Piccirillo, Roldano Fossati, Gaia Giannone, Laura Arenare, Ciro Gallo, Francesco Perrone, Sandro Pignata

International Journal of Gynecologic Cancer Jun 2021, 31 (6) 875-882; DOI: 10.1136/ijgc-2021-002434
Clear cell carcinoma of the ovary: a clinical and molecular perspective
Yasushi Iida, Aikou Okamoto, Robert L Hollis, Charlie Gourley, C Simon Herrington

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 605-616; DOI: 10.1136/ijgc-2020-001656
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Antonio Gonzalez Martin, Luisa Sanchez Lorenzo, Nicoletta Colombo, René dePont Christensen, Florian Heitz, Mihai Meirovitz, Frederic Selle, Toon van Gorp, Nuria Alvarez, Javier Sanchez, Carmen Marqués

International Journal of Gynecologic Cancer Apr 2021, 31 (4) 617-622; DOI: 10.1136/ijgc-2020-001633
ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Osnat Elyashiv, Jonathan Ledermann, Gita Parmar, Laura Farrelly, Nicholas Counsell, Amanda Feeney, Fatima El-Khouly, Ian Macdonald, Andreia Neto, Esther Arthur-Darkwa, Eva Burnett, Gordon C Jayson, Linda Mileshkin, Charlie Gourley, Shibani Nicum

International Journal of Gynecologic Cancer Jan 2021, 31 (1) 134-138; DOI: 10.1136/ijgc-2020-002073
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Shih-Ern Yao, Lee Tripcony, Karen Sanday, Jessica Robertson, Lewis Perrin, Naven Chetty, Russell Land, Andrea Garrett, Andreas Obermair, Marcelo Nascimento, Amy Tang, Nisha Jagasia, Piksi Singh, Jim Nicklin

International Journal of Gynecologic Cancer Dec 2020, 30 (12) 1935-1942; DOI: 10.1136/ijgc-2020-001658
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, Peter H Sykes, Ewa Zotow, Samantha Harrison

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1748-1756; DOI: 10.1136/ijgc-2020-001403

Main menu

medical oncology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

medical oncology

Pages